Burkitt's lymphoma

Oral Oncology

Volumn 34, Issue 1, 1998, Pages 15-23

  Shapira, J ^a   Peylan Ramu, N ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

AIDS; Burkitt's lymphoma; Clinical characteristics; Epidemiology; Epstein Barr virus

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BURKITT LYMPHOMA; CLINICAL FEATURE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; HUMAN; INCIDENCE; PRIORITY JOURNAL; REVIEW; SOCIOECONOMICS;

EID: 0031897152     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(97)00041-9     Document Type: Review

References (95)

1. [1] Young JL, Ries LG, Silverberg E, Horm JW, Miller R.W. Cancer incidence, survival and mortality for children younger than age 15 years. Cancer 1986;58:598-602.
2. [2] Magrath IT. African Burkitt's lymphoma: histology, biology, clinical features, and treatment. American Journal of Pediatric Hematology/Oncology 1991;13:222-246.
3. [3] National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-2135.
4. [4] Pedrosa F, Fonseca T, Leimig T, Verissimo L, Ribeirio R. C, Sandlund J. Clinical and biological characteristics of childhood non-Hodgkin's lymphoma (NHL) in northeast Brazil. Medical and Pediatric Oncology 1993;21:532 (abstract).
5. [5] Sandlund JT, Downing JR, Crist WM. Non-Hodgkin's lymphoma in children. New England Journal of Medicine 1996;334:1238-1248.
6. [6] Philip T. Burkitt's Lymphoma in Europe. In: Lenoir G, O'Conor G, Olweny CLM, editors. Burkitt's Lymphoma. A Human Cancer Model. Lyon: IARC Scientific Publications 1985: 107-118.
7. [7] Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. New England Journal of Medicine 1984;311:565-570.
8. [8] Subar M, Neri A, Inghirami G, et al. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988;72:667-671.
9. [9] Little C. Burkitt's Lymphoma. In: Moossa AR, Robson MC, Schimpff SC, editors. Oncology. Williams & Wilkins, Baltimore, 1986:593-597.
10. [10] Burkitt DP, Wright DH. Burkitt's Lymphoma. Edinburgh: E&S Livingstone, 1970.
11. [11] Hesselling P, Wood RE, Nortje CJ, Mouton S. African Burkitt's Lymphoma in the Cape province of South Africa and in Namibia. Oral Surgery 1989;68:162-166.
12. [12] Adatia AK. Burkitt's tumor in the jaws. British Dental Journal 1966;120:315-326.
13. [13] Adatia AK. Significance of jaw lesions in Burkitt's Lymphoma. British Dental Journal 1978;145:263-266.
14. [14] Magrath IT, Sariban E. Clinical features of Burkitt's Lymphoma in the USA. In: Lenoir G, O'Conor G, Olweny CLM, editors. Burkitt's Lymphoma. A Human Cancer Model. Lyon: IARC Scientific Publications 1985:119-127.
15. [15] Bouffet E, Frappaz D, Pinkerton R, Favrot M, Philip T. Burkitt's Lymphoma: a model for clinical oncology. European Journal of Cancer 1991;27:504-509.
16. [16] Kearns DB, Smith RJH, Pitcock JK. Burkitt's Lymphoma. International Journal of Paediatric Otorhinolaryngology 1986;12:73-84.
17. [17] Ziegler JL. Treatment results of 54 American patients with Burkitt's Lymphoma are similar to the African experience. New England Journal of Medicine 1977;297:75-80.
18. [18] Epstein MA, Achong BG. The Epstein-Barr Virus. Berlin: Springer, 1979.
19. [19] Evans AS. Epidemiology of Burkitt's Lymphoma: other risk factors. In: Lenoir G, O'Conor G, Olweny CLM, editors. Burkitt's Lymphoma. A Human Cancer Model. Lyon: IARC Scientific Publications 1985:197-204.
20. [20] Lam KMC, Syed N, Whittle H, Crawford DH. Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet 1991;337:876-878.
21. [21] Facer CA, Playfair JHL. Malaria, Epstein-Barr virus, and the genesis of lymphomas. Advances in Cancer Research 1989;53:33-72.
22. [22] de-The G. The Epstein-Barr Virus in neoplasms of the head and neck. In: Johnson NW, editor. Oral Cancer, Cambridge University Press, Cambridge 1991:88-95.
23. [23] Shiramizu B, Barriga F, Neequaye J, et al., Patterns of chromosomal breakpoint locations in Burkitt's Lymphoma: Relevance to geography and Epstein-Barr virus association. Blood, 1991;77:1516-1526.
24. [24] Cavdar AO, Yavuz G, Babacan E, et al. Burkitt's Lymphoma in Turkish children: clinical, viral (EBV) and molecular studies. Leukemia and Lymphoma 1994;14:323-330.
25. [25] Anwar N, Kingma DW, Bloch AR, et al. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's Lymphoma from Egypt. Epidemiologic correlations. Cancer 1995;76:1245-1252.
26. [26] de-The G. Epstein-Barr virus and Burkitt's Lymphoma worldwide: the causal relationship revisited. In: Lenoir G, O'Conor G, Olweny CLM, editors. Burkitt's Lymphoma. A Human Cancer Model. Lyon: IARC Scientific Publications 1985:165-176.
27. [27] Gutierrez MI, Bhatia K, Barriga F, et al. Molecular epidemiology of Burkitt's Lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood 1992;79:3261-3266.
28. [28] Razzouk BI, Srinivas S, Sample CE, Singh V, Sixbey W. Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's Lymphoma. Journal of Infectious Diseases 1996;173:529-535.
29. [29] Magrath IT. Malignant non-Hodgkin's lymphomas in children. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology, 3rd edn, JB. Lippincott, Philadelphia 1997:545-587.
30. [30] Zech L, Haglund U, Nilsson K, Klein G. Characteristic chromosomal abnormalities in biopsies and lymphoid cell lines from patients with Burkitt's and non-Burkitt's lymphomas. International Journal of Cancer 1976;17:47-56.
31. [31] Croce CM, Nowell PC. Molecular basis of human B-cell neoplasia. Blood 1985;65:1-7.
32. [32] Olweny CLM, Katongole-Mbidde E, Otim D, Lwanga SK, Magrath IT, Ziegler JL. Long-term experience with Burkitt's Lymphoma in Uganda. International Journal of Cancer 1980;26:261-266.
33. [33] Biggar RJ, Nkrumah FK, Neequaye J, Levine PH. Changes in presenting tumour site of Burkitt's Lymphoma in Ghana, West Africa, 1965-1978. British Journal of Cancer 1981;43:632-636.
34. [34] Sobo AC. Cancer in Liberia: a review of cases registered from the Liberia Cancer Registry 1973-1977. Cancer 1982;49:1945-1951.
35. [35] Kalengayi MMR, Mubikayi L. Pathology of Burkitt's lymphoma in Zaire. In: Williams AO, O'Conor GT, De-The GB, Johnson CA, editors. Virus-associated Cancers in Africa, Lyon: IARC Scientific Publications 1984:655-664.
36. [36] Nkrumah FK. Changes in the presentation of Burkitt's Lymphoma in Ghana over a 15-year period (1969-1982). In: Williams AO, O'Conor GT, De-The GB, Johnson CA, editors. Virus-associated Cancers in Africa, Lyon: IARC Scientific Publications 1984:665-674.
37. [37] Geser A, Brubaker G. A preliminary report of epidemiological studies of Burkitt's Lymphoma, Epstein-Barr virus infection and malaria in North Mara, Tanzania. In: Lenoir G, O'Conor G, Olweny CLM, editors. Burkitt's Lymphoma. A Human Cancer Model, Lyon: IARC Scientific Publications 1985:205-215.
38. [38] Daniel E. Burkitt's lymphoma in Ethiopian children. Tropical and Geographical Medicine 1990;42:255-260.
39. [39] Obafunwa JO, Akinsete I. Malignant lymphoma in Jos, Nigeria: a ten-year study. Central African Journal of Medicine 1992;38:17-25.
40. [40] Makata AM, Toriyama K, Kamidigo NO, Eto H, Itakura H. The pattern of pediatric solid malignant tumors in Western Kenya, East Africa, 1979-1994: an analysis based on histopathologic study. American Journal of Tropical Medicine and Hygiene 1996;54:343-347.
41. [41] Levine PH, Kamaraju LS, Connelly RR, et al., The American Burkitt's Lymphoma registry: eight years experience. Cancer, 1982;49:1016-1022.
42. [42] Kemeny MM, Magrath IT, Brennan MF. The role of surgery in the management of American Burkitt's lymphoma and its treatment. Annals of Surgery 1982;196:82-86.
43. [43] Levine AM, Pavlova Z, Pockros AW, et al. Small noncleaved follicular center cell (FCC) lymphoma: Burkitt and non-Burkitt variants in the United States. Cancer 1983;52:1073-1079.
44. [44] Sariban E, Donahue A, Magrath IT. Jaw involvement in American Burkitt's Lymphoma. Cancer 1984;53:1777-1782.
45. [45] Hutchinson RE, Murphy SB, Fairclough DL, et al. Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non-Burkitt's types. Cancer 1989;64:23-28.
46. [46] Patton LL, McMillan CW, Webster WP. American Burkitt's lymphoma: a 10-year review and case study. Oral Surgery 1990;69:307-316.
47. [47] Stovroff MC, Coran AG, Hutchinson RJ. The role of surgery in American Burkitt's lymphoma in children. Journal of Pediatric Surgery 1991;26:1235-1238.
48. [48] Wang MB, Strasnick B, Zimmerman MC. Extranodal American Burkitt's Lymphoma of the head and neck. Archives of Otolaryngology - Head and Neck Surgery 1992;118:193-199.
49. [49] Shamberger RC, Weinstein HJ. The role of surgery in abdominal Burkitt's Lymphoma. Journal of Pediatric Surgery 1992;27:236-240.
50. [50] Aghai E, Hulu N, Virag I, Kende G, Ramot B. Childhood non-Hodgkin's Lymphoma - a study of 17 cases in Israel. Cancer 1974;33:1411-1416.
51. [51] Al-Attar A, Al-Mondhiry H, Al-Bahrani Z, Al-Saleem T. Burkitt's Lymphoma in Iraq. Clinical and pathological study of forty-seven patients. International Journal of Cancer 1979;23:14-17.
52. [52] Anaissie E, Geha S, Allam C, Jabbour J, Khalyl M, Salem P. Burkitt's Lymphoma in the Middle East. A study of 34 cases. Cancer 1985;56:2539-2543.
53. [53] Madanat FF, Amr SS, Tarawneh MS, El-Khateeb MS, Marar B. Burkitt's Lymphoma in Jordanian children: epidemiological and clinical study. Journal of Tropical Medicine and Hygiene 1986;89:189-191.
54. [54] Anavi Y, Kaplinsky C, Calderon S, Zaizov R. Head neck and maxillofacial childhood Burkitt's Lymphoma: a retrospective analysis of 31 patients. Journal of Maxillofacial Surgery 1990;48:708-713.
55. [55] Cavdar AO, Gozdasoglu S, Yavuz G, et al. Burkitt's Lymphoma between African and American types in Turkish children: clinical, viral (EBV), and molecular studies. Medical and Pediatric Oncology 1993;21:36-42.
56. [56] Shapira J, Peylan-Ramu N, Lustmann J. Retrospective epidemiological study of Burkitt's Lymphoma in Israel and diagnosis by a conservative incisional biopsy. Oral Oncology, European Journal of Cancer 1995;31B:319-322.
57. [57] Wright D. Burkitt's tumour in England. A comparison with childhood lymphosarcoma. International Journal of Cancer 1966;1:503-514.
58. [58] Philip T, Lenoir GM, Bryon PA, et al. Burkitt-type Lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children. British Journal of Cancer 1982;45:670-678.
59. [59] Bureo E, Ortega JJ, Munoz A, et al. Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma. Bone Marrow Transplantation 1995;15:353-359.
60. [60] Miyoshi I. Burkitt's Lymphoma in Japan. In: Lenoir G, O'Conor G, Olweny CLM, editors. Burkitt's Lymphoma. A Human Cancer Model, Lyon: IARC Scientific Publications 1985:135-147.
61. [61] Chan JKC, Tsang WYW, Wong CSC, Lo ESF. A study of the association of Epstein-Barr virus with Burkitt's Lymphoma occurring in a Chinese population. Histopathology 1995;26:239-245.
62. [62] Shanmugaratnam KK, Tan KK, Lee KW. Lymphoma of the Burkitt type in Singapore. International Journal of Cancer 1967;2:576-580.
63. [63] Aboulola M, Boukheloua B, Ladjadj Y, Tazerout FZ. Burkitt's Lymphoma in Algeria. In: Lenoir G, O'Conor G, Olweny CLM, editors. Burkitt's Lymphoma. A Human Cancer Model, Lyon: IARC Scientific Publications 1985:97-105.
64. [64] Araujo I, Foss HD, Bittencourt A, et al., Expression of Epstein-Barr virus gene products in Burkitt's Lymphoma in Northeast Brazil. Blood, 1996;87:5279-5286.
65. [65] Adatia AK. Dental tissues and Burkitt's tumor. Oral Surgery 1968;25:221-234.
66. [66] Lehner T. The jaws and teeth in Burkitt's tumor (African lymphoma). Journal of Pathology and Bacteriology (London) 1964;88:581-585.
67. [67] Sidhu SS, Sukhija DS, Parkash H. Burkitt's lymphoma. Oral Surgery 1975;39:463-468.
68. [68] Mundy GR, Ibbotson KJ, D'Souza SM, Simpson EL, Jacobs JW, Martin TJ. The hypercalcemia of cancer. New England Journal of Medicine 1984;310:1718-1727.
69. [69] Hupp JR, Collins FJV, Ross A, Myall RWT. A review of Burkitt's Lymphoma: importance of radiographic diagnosis. Journal of Maxillofacial Surgery 1982;10:240-245.
70. [70] Adatia AK. Direct evidence of epithelial-mesenchymal interdependence in situ. Journal of Anatomy 1980;130:469-478.
71. [71] Welbury RR, Craft AN, Murray JJ, Kernahan J. Dental health of survivors of malignant disease. Archives of Disease in Childhood 1984;59:1186-1187.
72. [72] Macleod RI, Welburry RR, Soames JV. Effects of cytotoxic chemotherapy on dental development. Journal of the Royal Society of Medicine 1987;80:207-209.
73. [73] Adatia AK. Effects of cytotoxic chemotherapy on dental development. Journal of the Royal Society of Medicine 1987;80:784-785 (letter).
74. [74] Asamoa EA, Ayanlere AO, Olaitan AA, Akekeye EO. Paediatric tumours of the jaws in Northern Nigeria. Journal of Craniomaxillofacial Surgery 1990;18:130-135.
75. [75] Arotiba GT. Study of orofacial tumors in Nigerian children. Journal of Oral Maxillofacial Surgery 1996;54:34-38.
76. [76] Pagano JS, Huang CH, Levine P. Absence of Epstein-Barr viral DNA in American Burkitt's lymphoma. New England Journal of Medicine 1973;289:1395-1399.
77. [77] Ziegler JL, Andersson M, Klein G, Henle W. Detection of Epstein-Barr virus DNA in American Burkitt's lymphoma. International Journal of Cancer 1976;17:701-706.
78. [78] Andersson M, Klein G, Ziegler JL, Henle W. Association of Epstein-Barr viral genomes with Burkitt lymphoma. Nature 1976;260:357-359.
79. [79] Ladjadj Y, Philip T, Lenoir GM, et al., Abdominal Burkitt-type lymphomas in Algeria. British Journal of Cancer, 1984;49:503-512.
80. [80] Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin lymphoma. The Lancet 1991;337:805-809.
81. [81] Kristal AR, Nasca PC, Burnet WS, Miki J. Changes in the epidemiology of non-Hodgkin's lymphoma associated with epidemic human immunodeficiency virus (HIV) infection. American Journal of Epidemiology 1988;128:711-718.
82. [82] Epstein JB, Silverman S. Head and neck malignancies associated with HIV infection. Oral Surgery 1992;73:193-200.
83. [83] Berkowitz R, Frenkel LM. Cancer in the HIV-infected child. Pediatric Dentistry 1996;18:127-128.
84. [84] Serraino D, Salamina G, Franceschi S, et al. The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the World Health Organization European Region. British Journal of Cancer 1992;66:912-916.
85. [85] Ng VL, Khayam-Bashi F, Marsh J, McGrath MS. Serologic analysis of proteins associated with and preliminary seroprevalence studies of two novel retroviruses isolated from AIDS-associated lymphomas. IVth International Conference on AIDS, Montreal, Canada, 1989, c777 (abstract):688.
86. [86] Aisenberg A. Coherent view of Non-Hodgkin's Lymphoma. Journal of Clinical Oncology 1995;13:2656-2675.
87. [87] Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. Human c-myc one gene is located on the region of chromosome 8 that is translated in Burkitt's lymphoma cells. Proceedings of the National Academy of Sciences USA 1982;79:7824-7827.
88. [88] Magrath IT. The pathogenesis of Burkitt's lymphoma. Advances in Cancer Research 1990;55:133-270.
89. [89] Shiramizu B, Magrath IT. Localization of breakpoints by polymerase chain reactions in Burkitt's Lymphoma with 8;14 translocations. Blood 1990;75:1848-1852.
90. [90] Bhatia K, Huppi K, Splanger G. Point mutation in the transactivation domain of c-myc are common in Burkitt's lymphoma and Mouse Plasmacytomas. Nature Genetics 1993;5:56.
91. [91] Blay JY, Louis D, Bouffet E, et al. Management of pediatric non-Hodgkin's lymphoma. Blood Reviews 1991;5:90-97.
92. [92] Murphy SB, Fairclough DL, Hutchison RE, Berard CW. Non-Hodgkin's Lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. Journal of Clinical Oncology 1989;7:186-193.
93. [93] Magrath IT, Janus C, Eduards B, et al. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood, 1984;63:1102-1111.
94. [94] White L, Siegel SE, Quah TC. Non-Hodgkin's lymphoma in children. 2: treatment. Critical Reviews in Oncology/Haematology 1992;13:73-89.
95. [95] Link MP, Donaldson SS, Berard CW, Shaster JJ, Murphy SB. Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. New England Journal of Medicine 1990;322:1169-1174.